GlassScriptPhysician profile
Anilkumar O Mehra
NPI 1780622175
$3,850.02
in general payments reported to CMS, 2019-2025
18 companies · $572 in 2025
The $572 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $84.05 · 2021: $233 · 2022: $945 · 2023: $944 · 2024: $854 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,368.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $884.69 | 2021-2025 | Impella |
| Boston Scientific Corporation | $648.35 | 2019-2024 | Avvigo Guidance System, Rotapro, Sentinel |
| Abbott Laboratories | $598.88 | 2019-2025 | Pressurewire, Ultreon, Optis |
| Shockwave Medical, INC | $445.46 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $254.56 | 2023-2024 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.29 | 2020-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $158.80 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $121.82 | 2023 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $108.41 | 2021 | |
| Medtronic, INC. | $85.53 | 2021-2025 | Melody Tpv, Harmony |
| Novartis Pharmaceuticals Corporation | $79.84 | 2021-2022 | |
| Getinge USA Sales, LLC | $64.34 | 2019-2022 | |
| Teleflex LLC | $52.70 | 2021-2023 | Guideliner |
| Philips North America LLC | $50.28 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $39.93 | 2023 | Praluent, Evkeeza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $34.12 | 2020 | |
| Cook Medical LLC | $16.16 | 2023 | Evolution |
| Ge Healthcare | $15.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anilkumar Mehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.